Friday – Clinical Track 3A

Full Name(Required)
Enter your first and last names as you would like them to appear on your certificates.
Enter the email you used to register for TOXINS 2022.

Please evaluate the speakers

ExcellentGoodFairPoor
Update on Hyperhidrosis (Dee Anna Glaser)
Micro Toxin Technique: What, Why, and Where? (Woffles Wu)
Subject Satisfaction With Two Treatments Per Year (Every Six Months) of AbobotulinumtoxinA Is High Among Both Previously Treated and Toxin-naïve Cohorts (Sarah Coquis-Knezek)
The Air Toxin Technique: Introduction and Analysis of Effect Using a Photo Imaging System (Hei Sung Kim)
YesNo
Update on Hyperhidrosis (Dee Anna Glaser)
Micro Toxin Technique: What, Why, and Where? (Woffles Wu)
Subject Satisfaction With Two Treatments Per Year (Every Six Months) of AbobotulinumtoxinA Is High Among Both Previously Treated and Toxin-naïve Cohorts (Sarah Coquis-Knezek)
The Air Toxin Technique: Introduction and Analysis of Effect Using a Photo Imaging System (Hei Sung Kim)
YesNo
Update on Hyperhidrosis (Dee Anna Glaser)
Micro Toxin Technique: What, Why, and Where? (Woffles Wu)
Subject Satisfaction With Two Treatments Per Year (Every Six Months) of AbobotulinumtoxinA Is High Among Both Previously Treated and Toxin-naïve Cohorts (Sarah Coquis-Knezek)
The Air Toxin Technique: Introduction and Analysis of Effect Using a Photo Imaging System (Hei Sung Kim)
Strongly disagreeDisagreeNeutralAgreeStrongly agree
Ability to evaluate the latest clinical and scientific research into botulinum neurotoxins
Understanding of the clinical utility of botulinum neurotoxins
Understanding of potential new therapeutic applications of botulinum neurotoxins
Biomedical knowledge of botulinum and other neurotoxins and their application in enhancing therapeutics and improving care
Strongly disagreeDisagreeNeutralAgreeStrongly agree
Research methodology
Focus and/or direction of research
Translation of research to therapeutic applications
Other

Join Our Mailing List

Click here to sign up, and then manage your subscription.